Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 330 participants.
Also called NCT07073469
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 330 participants
- Registry
-
NCT07073469
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07073469. Randomized; double masking; primary purpose treatment. Start 2025-09-01 (anticipated); primary completion 2027-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial
- Condition
- Stroke Ischemic
- Intervention (Drug)
- Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
- Intervention (Other)
- Standard medical treatment
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct07073469- Content hash
95a6f51ae12d4ac56e91f3ea60ff0e8646da17272ca7e3e645527d2576b3cd6d